New Nanoparticle Research Targets Cancer
3rd September 2015
At Richardsons, we are always enthusiastic in supporting, and being part of, Oxfordshire's vibrant innovation community. We are proud to have been involved in assisting Xerion Healthcare, an Oxford University spin-out undertaking research into the use of nanoparticles to target malignant tumours, in conjunction with radiotherapy treatment. The company has raised equity funding of £1.5m to continue the development of the technique.
Read more here.